Nifty
:
24355.75
Sensex
:
80353.19
69.25 (0.29%)
366.39 (0.46%)
Nifty
Sensex
:
:
24355.75
80353.19
69.25 (0.29%)
366.39 (0.46%)

Themis Medicare Ltd.

Pharmaceuticals & Drugs - Global

Rating :
47/99

BSE: 530199 | NSE: THEMISMED

NSE BSE
206.22
03-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  213.00
  •  213.00
  •  205.30
  •  209.98
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  54047
  •  112.64
  •  263.85
  •  132.60

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 1,893.27
  • 43.50
  • 1
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 1,969.76
  • 0.24%
  • 5.01

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 67.15%
  • 3.93%
  • 23.31%
  • FII
  • DII
  • Others
  • 0.03%
  • 0.00%
  • 5.58%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 6.58
  • 13.62
  • -1.10

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 11.10
  • 7.63
  • -11.64

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 23.11
  • 22.34
  • -15.79

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 23.06
  • 14.96
  • 21.10

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.18
  • 3.13
  • 4.00

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 19.42
  • 21.35
  • 17.72

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Net Sales
97.82
80.10
22.12%
82.51
88.78
-7.06%
104.78
91.00
15.14%
96.65
94.44
2.34%
Expenses
88.52
69.62
27.15%
74.45
73.51
1.28%
92.38
69.66
32.62%
74.91
74.08
1.12%
EBITDA
9.30
10.48
-11.26%
8.06
15.27
-47.22%
12.40
21.34
-41.89%
21.74
20.36
6.78%
EBIDTM
9.50%
13.08%
9.77%
17.20%
11.84%
23.45%
22.50%
21.56%
Other Income
1.10
2.95
-62.71%
0.57
5.90
-90.34%
2.44
1.97
23.86%
0.65
0.69
-5.80%
Interest
2.16
2.71
-20.30%
2.69
2.23
20.63%
2.04
2.37
-13.92%
2.49
2.26
10.18%
Depreciation
3.06
2.80
9.29%
3.10
2.67
16.10%
3.07
2.56
19.92%
3.02
2.46
22.76%
PBT
5.18
7.92
-34.60%
2.85
16.27
-82.48%
9.74
18.38
-47.01%
16.88
16.33
3.37%
Tax
2.11
1.89
11.64%
0.85
4.19
-79.71%
2.64
4.85
-45.57%
4.32
4.69
-7.89%
PAT
3.07
6.04
-49.17%
2.00
12.08
-83.44%
7.10
13.53
-47.52%
12.55
11.63
7.91%
PATM
3.14%
7.54%
2.42%
13.61%
6.77%
14.87%
12.99%
12.32%
EPS
0.72
0.91
-20.88%
0.80
1.45
-44.83%
1.23
1.93
-36.27%
1.98
1.89
4.76%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Net Sales
-
381.76
354.32
394.61
230.67
201.59
183.75
209.50
216.66
232.43
201.88
Net Sales Growth
-
7.74%
-10.21%
71.07%
14.43%
9.71%
-12.29%
-3.30%
-6.78%
15.13%
 
Cost Of Goods Sold
-
115.43
100.52
131.00
67.35
51.97
58.82
57.75
55.66
71.38
79.51
Gross Profit
-
266.33
253.81
263.62
163.33
149.62
124.94
151.75
160.99
161.06
122.37
GP Margin
-
69.76%
71.63%
66.81%
70.81%
74.22%
67.99%
72.43%
74.31%
69.29%
60.62%
Total Expenditure
-
330.26
286.87
298.98
181.18
165.93
181.48
184.98
184.29
194.28
183.91
Power & Fuel Cost
-
13.46
11.83
12.18
11.32
11.49
9.70
8.41
9.77
10.83
8.36
% Of Sales
-
3.53%
3.34%
3.09%
4.91%
5.70%
5.28%
4.01%
4.51%
4.66%
4.14%
Employee Cost
-
82.41
66.15
51.97
39.99
44.28
45.69
44.65
40.00
36.30
32.64
% Of Sales
-
21.59%
18.67%
13.17%
17.34%
21.97%
24.87%
21.31%
18.46%
15.62%
16.17%
Manufacturing Exp.
-
41.64
36.95
40.23
21.41
24.01
22.45
27.46
31.30
31.28
21.69
% Of Sales
-
10.91%
10.43%
10.19%
9.28%
11.91%
12.22%
13.11%
14.45%
13.46%
10.74%
General & Admin Exp.
-
29.71
24.29
18.66
12.03
14.05
17.57
18.93
18.86
14.75
13.52
% Of Sales
-
7.78%
6.86%
4.73%
5.22%
6.97%
9.56%
9.04%
8.70%
6.35%
6.70%
Selling & Distn. Exp.
-
29.30
26.74
26.08
14.92
12.28
17.71
18.27
16.70
12.05
10.87
% Of Sales
-
7.67%
7.55%
6.61%
6.47%
6.09%
9.64%
8.72%
7.71%
5.18%
5.38%
Miscellaneous Exp.
-
18.30
20.40
18.86
14.16
7.86
9.54
9.51
11.99
17.69
10.87
% Of Sales
-
4.79%
5.76%
4.78%
6.14%
3.90%
5.19%
4.54%
5.53%
7.61%
8.58%
EBITDA
-
51.50
67.45
95.63
49.49
35.66
2.27
24.52
32.37
38.15
17.97
EBITDA Margin
-
13.49%
19.04%
24.23%
21.45%
17.69%
1.24%
11.70%
14.94%
16.41%
8.90%
Other Income
-
4.76
11.50
6.54
3.62
3.46
2.67
3.49
3.32
3.19
12.59
Interest
-
9.38
9.56
8.77
12.71
12.88
11.82
11.87
11.84
12.33
14.53
Depreciation
-
12.25
10.49
9.48
8.55
8.27
7.99
7.42
7.47
11.89
11.49
PBT
-
34.64
58.90
83.92
31.86
17.97
-14.87
8.74
16.37
17.13
4.54
Tax
-
9.92
15.61
22.38
5.63
2.09
-1.84
0.10
1.60
1.91
-0.89
Tax Rate
-
28.64%
26.50%
26.67%
17.67%
11.63%
12.37%
1.14%
9.77%
11.15%
-19.60%
PAT
-
43.52
56.90
72.88
26.23
15.88
-13.01
8.70
14.77
15.22
5.44
PAT before Minority Interest
-
43.52
56.90
72.88
26.23
15.88
-13.03
8.64
14.77
15.22
5.44
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.02
0.06
0.00
0.00
0.00
PAT Margin
-
11.40%
16.06%
18.47%
11.37%
7.88%
-7.08%
4.15%
6.82%
6.55%
2.69%
PAT Growth
-
-23.51%
-21.93%
177.85%
65.18%
-
-
-41.10%
-2.96%
179.78%
 
EPS
-
4.73
6.18
7.92
2.85
1.73
-1.41
0.95
1.61
1.65
0.59

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Shareholder's Funds
377.67
339.44
287.49
218.51
183.02
158.09
168.91
152.44
74.03
59.20
Share Capital
9.20
9.20
9.20
9.19
9.19
9.18
9.18
9.04
8.52
8.47
Total Reserves
368.46
330.17
278.05
208.95
173.35
148.31
159.18
141.36
65.51
50.73
Non-Current Liabilities
34.17
35.39
30.77
24.33
7.51
2.71
6.72
7.60
70.83
82.04
Secured Loans
21.19
18.62
10.91
5.73
0.09
0.14
0.01
0.47
15.89
18.83
Unsecured Loans
5.59
9.83
12.97
16.47
11.76
9.21
11.48
11.93
47.52
55.81
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.54
0.49
Current Liabilities
163.88
149.38
123.52
128.31
154.81
146.69
124.94
124.17
129.66
135.61
Trade Payables
47.29
40.04
31.87
30.79
29.68
35.04
30.55
31.63
34.90
60.15
Other Current Liabilities
49.95
40.28
29.93
39.09
46.86
43.72
29.76
38.13
37.04
16.51
Short Term Borrowings
47.36
48.91
43.10
56.93
76.61
66.86
63.73
53.45
51.88
53.78
Short Term Provisions
19.28
20.14
18.61
1.49
1.66
1.07
0.90
0.95
5.83
5.17
Total Liabilities
575.72
524.21
441.78
371.15
345.34
307.47
300.51
284.21
274.52
276.85
Net Block
168.37
162.20
144.00
133.10
116.31
123.41
125.90
123.71
117.35
122.32
Gross Block
239.28
221.02
192.36
172.24
147.14
146.06
140.78
131.17
212.16
206.19
Accumulated Depreciation
70.92
58.82
48.36
39.14
30.83
22.66
14.87
7.46
94.80
83.87
Non Current Assets
273.25
249.43
213.62
185.67
164.85
157.61
157.47
159.81
141.68
143.38
Capital Work in Progress
2.60
2.60
2.56
2.47
7.54
2.45
2.47
8.95
5.79
3.50
Non Current Investment
88.89
70.00
56.31
44.96
35.47
26.64
24.38
21.83
5.64
4.59
Long Term Loans & Adv.
12.46
12.81
6.90
2.83
2.91
2.67
2.39
3.01
12.19
12.70
Other Non Current Assets
0.93
1.82
3.84
2.31
2.62
2.45
2.33
2.30
0.70
0.28
Current Assets
302.47
274.78
228.16
185.47
180.49
149.86
143.04
124.40
132.83
133.47
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
1.05
0.00
0.00
Inventories
70.57
68.95
60.81
58.49
54.61
53.63
49.58
48.44
58.26
62.30
Sundry Debtors
177.95
145.02
100.56
77.61
102.48
72.91
68.63
48.25
47.57
45.56
Cash & Bank
19.30
18.89
26.50
24.63
5.29
3.45
6.91
8.62
14.30
8.70
Other Current Assets
34.65
6.67
5.94
5.89
18.11
19.87
17.91
18.04
12.70
16.92
Short Term Loans & Adv.
27.21
35.24
34.34
18.84
12.28
14.45
12.57
12.72
11.34
15.58
Net Current Assets
138.58
125.40
104.64
57.16
25.68
3.18
18.09
0.23
3.18
-2.14
Total Assets
575.72
524.21
441.78
371.14
345.34
307.47
300.51
284.21
274.51
276.85

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Cash From Operating Activity
22.09
16.09
34.39
56.98
0.33
10.92
7.86
-1.51
25.76
19.09
PBT
53.44
72.51
95.26
41.33
26.87
-12.60
11.33
17.56
30.52
19.85
Adjustment
-1.48
0.03
-0.24
7.66
9.33
16.74
14.93
15.92
10.05
10.48
Changes in Working Capital
-20.92
-40.30
-42.55
7.90
-35.63
7.08
-19.05
-35.16
-0.57
2.40
Cash after chg. in Working capital
31.05
32.25
52.47
56.90
0.57
11.22
7.21
-1.67
40.00
32.73
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
-12.33
-14.53
Tax Paid
-8.96
-16.15
-18.07
0.08
-0.24
-0.30
0.65
0.16
-1.91
0.89
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-15.95
-23.96
-15.59
-15.65
-5.47
-3.72
-0.04
-4.14
-7.17
-6.27
Net Fixed Assets
-18.26
-28.70
-20.21
-20.03
-6.16
-5.34
-3.11
20.82
-6.64
-2.13
Net Investments
-0.11
-0.05
-0.03
-0.02
0.06
-0.01
1.01
-1.33
0.01
-0.23
Others
2.42
4.79
4.65
4.40
0.63
1.63
2.06
-23.63
-0.54
-3.91
Cash from Financing Activity
-8.77
0.14
-17.55
-25.65
6.72
-9.94
-9.11
5.27
-13.29
-17.96
Net Cash Inflow / Outflow
-2.62
-7.73
1.26
15.68
1.59
-2.74
-1.29
-0.38
5.31
-5.14
Opening Cash & Equivalents
12.55
20.28
19.02
3.34
1.75
4.49
5.78
6.16
-39.67
-34.53
Closing Cash & Equivalent
9.92
12.55
20.28
19.02
3.34
1.75
4.49
5.78
-34.36
-39.67

Financial Ratios

Consolidated /

Standalone
Description
Mar 24
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Book Value (Rs.)
41.03
36.88
31.22
237.41
198.67
171.54
183.39
166.38
86.94
69.91
ROA
7.91%
11.78%
17.93%
7.32%
4.86%
-4.29%
2.95%
5.29%
5.52%
1.94%
ROE
12.14%
18.16%
28.84%
13.09%
9.34%
-8.00%
5.42%
13.16%
22.85%
9.40%
ROCE
13.88%
20.59%
31.07%
15.21%
11.81%
-1.25%
8.52%
12.92%
14.69%
9.45%
Fixed Asset Turnover
1.66
1.71
2.16
1.44
1.38
1.28
1.56
1.32
1.13
1.03
Receivable days
154.39
126.49
82.40
142.49
158.78
140.57
100.75
77.33
72.04
76.05
Inventory Days
66.70
66.84
55.18
89.48
97.99
102.51
84.49
86.11
93.26
114.91
Payable days
138.08
130.58
87.30
163.89
75.58
71.78
69.42
73.88
99.57
126.74
Cash Conversion Cycle
83.02
62.75
50.27
68.08
181.20
171.29
115.83
89.56
65.73
64.22
Total Debt/Equity
0.25
0.27
0.27
0.39
0.54
0.52
0.48
0.55
1.73
2.37
Interest Cover
6.70
8.58
11.86
3.51
2.40
-0.26
1.74
2.38
2.39
1.31

Annual Reports:

FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015

News Update:


  • Themis Medicare - Quarterly Results
    14th May 2024, 21:45 PM

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.